Online Inquiry

For Research Use Only. Not For Clinical Use.

Contact Us
  • Email:

GABAergic Neuron Progenitor Differentiation Service

Introduction GABAergic Neuron Progenitor Differentiation Service Workflow What We Can Offer Case Study FAQ
Inquiry Now

Introduction

GABAergic neurons serve as the main inhibitory neurons in the CNS, and their accurate differentiation relies on simulating ventral forebrain development signals. Creative Biolabs provides a professional GABAergic Neuron Progenitor Differentiation service using iPSC reprogramming and small-molecule regulation. The service generates high-purity, mature inhibitory neurons expressing GAD65/67, VGAT, and DLX2, supporting E/I balance research, neurotoxicity tests, and drug screening for epilepsy and ASD.

Discover How We Can Help - Request a Consultation

GABAergic Neuron Progenitor Differentiation Service

GABAergic neuron progenitors are neural precursor cells committed to the inhibitory neuronal lineage, essential for maintaining CNS excitatory--inhibitory balance and modeling epilepsy, autism, schizophrenia, and neurodegenerative diseases.

Key Features

  • Derived from human iPSCs/ESCs under defined, xeno-free conditions
  • Uses dual SMAD inhibition and SHH patterning for high-efficiency specification
  • Generates regionally specified progenitors (pallial, subpallial, striatal)
  • High expression of key markers: DLX1/2, LHX6, GAD67, NKX2.1

Service Content

  1. GABAergic progenitor induction & expansion
  2. Maturation into functional GABAergic neurons
  3. Quality validation: immunofluorescence, qPCR, flow cytometry
  4. Optional: electrophysiology, co-culture, disease modeling

Applications

  • Disease modeling (epilepsy, ASD, Huntington's disease)
  • High‑throughput drug screening & neurotoxicity testing
  • Cell therapy & neural circuit research
  • Neuron--glia co-culture & assembloid systems

Workflow

Our streamlined process is designed for transparency and scientific rigor, ensuring that every batch of GABAergic progenitors meets the highest industry standards.

What We Can Offer

As a global leader in stem cell solutions, Creative Biolabs provides an unparalleled suite of services for GABAergic differentiation, scaling from boutique academic research to massive industrial drug screening campaigns.

One-stop Differentiation Service

Seamless transition from iPSC reprogramming and progenitor expansion to large-scale terminal neuron maturation.

Customized Cell Engineering

Specialized codon optimization and CRISPR-mediated gene editing to create disease-specific models or reporter lines tailored to your unique project goals.

Scalable Production Capability

Industrial-grade cultivation systems capable of producing over 109 high-purity GABAergic neurons per batch, supporting large-scale high-throughput screening (HTS).

Advanced Quality Systems

Implementation of Quality-by-Design (QbD) and Process Analytical Techniques (PAT) to ensure batch-to-batch consistency in marker expression and functional maturity.

Rigorous Aseptic Verification

Strict aseptic procedures and environmental controls throughout the differentiation and cryopreservation process to guarantee contaminant-free products.

Optimized Culture Regimes

Expert optimization of media compositions and small-molecule cocktails to maximize yield and enhance the stability of MGE-like progenitor identities.

All-side Documentation

Full assessment and approval of cell line origin and stability by our qualified Quality Assurance (QA) service, following the basic principles of Good Manufacturing Practice (GMP).

Functional Validation Tools

High-standard quality control using Patch-clamp and Multi-electrode Array (MEA) to quantify the inhibitory potency and quality of every delivered cell lot.

Experience the Creative Biolabs Advantage - Get a Quote Today

Case Study

To compare developmental and functional differences between bipolar (BP), CRISPR-corrected (BP‑C), and control (C) cells, researchers generated GABAergic neurons using a modified protocol with SAG instead of SHH. After 6 weeks of differentiation, they performed qRT‑PCR, immunocytochemistry, SEM, RNA‑seq, MEA, and calcium imaging.

The results showed that all groups highly expressed GAD67, GAD65/67, NK2.1, Foxp1, and MAP2, with low levels of astrocyte and glutamatergic markers. All groups exhibited normal neuronal morphology. Researchers successfully established >85% pure GABAergic neuron cultures with only minor differences among BP, BP‑C, and C groups, providing a stable model for investigating neuronal function and development.

The scheme for differentiating GABAergic neurons from iPSCs. (OA Literature) Fig.1 iPSC-derived GABAergic neurons verified for marker expression and morphology.1

Customer Reviews

FAQs

Q: Can your GABAergic neuron progenitors be directly differentiated into mature functional interneurons?

A: Yes. Our GABAergic progenitors are fully patterned and can mature into functional inhibitory neurons with stable GAD65/67 expression and reliable synaptic activity in vitro.

Q: What key markers are used to validate the progenitors?

A: We validate purity and identity using critical markers including DLX2, LHX6, NKX2.1, GAD65/67, and VGAT, ensuring authentic ventral forebrain specification.

Q: Are the cells compatible with high-throughput screening (HTS)?

A: Yes. Our GABAergic progenitors show high batch consistency, uniform morphology, and robust viability, making them ideal for drug screening, MEA, and neurotoxicity assays.

Q: How long does the differentiation take?

A: The full protocol is highly streamlined. GABAergic progenitors are available in ~2-3 weeks, and mature functional neurons can be obtained within an additional 3-4 weeks.

Q: Do you provide custom disease-modeled cell lines?

A: Yes. We offer custom services including CRISPR editing, patient iPSC differentiation, and region-specific patterning to generate disease models for epilepsy, ASD, schizophrenia, and Huntington's disease.

Creative Biolabs provides end-to-end solutions for GABAergic Neuron Progenitor Differentiation. Our experts are ready to help you overcome your research bottlenecks.

Contact Our Team for More Information and to Discuss Your Project

Reference

  1. Schill, Daniel J., et al. "Human-induced pluripotent stem cell (iPSC)-derived GABAergic neuron differentiation in bipolar disorder." Cells 13.14 (2024): 1194. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/cells13141194.

For Research Use Only. Not For Clinical Use.

Inquiry Basket